SC 13G/A | 2008-02-13 | WILLIAM HARRIS INVESTORS INC | AspenBio Pharma, Inc. | 664,141 | 2.4% | EDGAR |
SC 13G/A | 2008-02-13 | Corriente Advisors, LLC | AspenBio Pharma, Inc. | 2,878,492 | 9.3% | EDGAR |
SC 13G/A | 2008-02-13 | Roaring Fork Capital SBIC, L.P. | AspenBio Pharma, Inc. | 1,142,857 | 3.7% | EDGAR |
SC 13G | 2007-11-29 | Corriente Advisors, LLC | AspenBio Pharma, Inc. | 1,628,199 | 5.8% | EDGAR |
SC 13G/A | 2007-02-14 | WILLIAM HARRIS INVESTORS INC | AspenBio Pharma, Inc. | 2,917,819 | 15.8% | EDGAR |
SC 13G/A | 2007-02-02 | Roaring Fork Capital SBIC, L.P. | AspenBio Pharma, Inc. | 1,911,481 | 9.5% | EDGAR |
SC 13G | 2007-01-25 | MARATHON CAPITAL MANAGEMENT | AspenBio Pharma, Inc. | 972,500 | 5.4% | EDGAR |
SC 13G | 2006-06-30 | RMB Capital Management, LLC | AspenBio Pharma, Inc. | 2,019,325 | - | EDGAR |
SC 13G/A | 2006-04-12 | WILLIAM HARRIS INVESTORS INC | AspenBio Pharma, Inc. | 2,585,419 | 16.1% | EDGAR |
SC 13G | 2006-04-11 | WILLIAM HARRIS INVESTORS INC | AspenBio Pharma, Inc. | 2,585,419 | 5.2% | EDGAR |
SC 13D/A | 2006-04-06 | TALON ASSET MANAGEMENT, LLC | AspenBio Pharma, Inc. | - | - | EDGAR |
SC 13D/A | 2006-02-14 | TALON ASSET MANAGEMENT, LLC | AspenBio Pharma, Inc. | 4,625,052 | 25.6% | EDGAR |
SC 13G/A | 2005-11-28 | Peierls Foundation, Inc. | AspenBio Pharma, Inc. | 2,044,727 | 12.2% | EDGAR |
SC 13G | 2005-05-16 | Roaring Fork Capital SBIC, L.P. | ASPENBIO INC | 2,285,714 | 14.0% | EDGAR |
SC 13G | 2005-05-16 | Peierls Foundation, Inc. | ASPENBIO INC | 1,999,220 | 12.3% | EDGAR |
SC 13D | 2005-05-13 | TALON ASSET MANAGEMENT INC | ASPENBIO INC | 4,571,428 | 26.1% | EDGAR |
SC 13G/A | 2005-02-11 | TALON ASSET MANAGEMENT INC | ASPENBIO INC | 2,285,714 | 17.8% | EDGAR |
SC 13G | 2004-08-27 | TALON ASSET MANAGEMENT INC | ASPENBIO INC | 2,285,712 | 17.8% | EDGAR |
SC 13D | 2003-06-27 | LIEBER HOWARD | ASPENBIO INC | 1,333,333 | 12.5% | EDGAR |